BRIEF-ImmunoCellular Rehabs deals with first client in ICT-107 stage 3 trial

Immunocellular Rehabs Ltd.
: * Reached contract with FDA on unique method evaluation.
relative to primary, secondary endpoints and statistical plan.
for stage 3 trial.

* Treats First Patient In Ict-107 stage 3 registrational.
trial in freshly identified Glioblastoma.

Source text for Eikon:.
Additional company protection:.

( Bengaluru Newsroom: +1 -646 -223 -8780).

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *